These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12356275)

  • 1. Inhibitory effect of fruit extracts on P-glycoprotein-related efflux carriers: an in-vitro screening.
    Deferme S; Van Gelder J; Augustijns P
    J Pharm Pharmacol; 2002 Sep; 54(9):1213-9. PubMed ID: 12356275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfasalazine transport in in-vitro, ex-vivo and in-vivo absorption models: contribution of efflux carriers and their modulation by co-administration of synthetic nature-identical fruit extracts.
    Mols R; Deferme S; Augustijns P
    J Pharm Pharmacol; 2005 Dec; 57(12):1565-73. PubMed ID: 16354400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apricot extract inhibits the P-gp-mediated efflux of talinolol.
    Deferme S; Mols R; Van Driessche W; Augustijns P
    J Pharm Sci; 2002 Dec; 91(12):2539-48. PubMed ID: 12434397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells.
    Mertens-Talcott SU; De Castro WV; Manthey JA; Derendorf H; Butterweck V
    J Agric Food Chem; 2007 Apr; 55(7):2563-8. PubMed ID: 17348674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of Tanzanian plant extracts for their potential inhibitory effect on P-glycoprotein mediated efflux.
    Deferme S; Kamuhabwa A; Nshimo C; de Witte P; Augustijns P
    Phytother Res; 2003 May; 17(5):459-64. PubMed ID: 12748979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells.
    Yoo HH; Lee M; Chung HJ; Lee SK; Kim DH
    J Agric Food Chem; 2007 Sep; 55(18):7620-5. PubMed ID: 17676865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT?
    Ofer M; Wolffram S; Koggel A; Spahn-Langguth H; Langguth P
    Eur J Pharm Sci; 2005 Jun; 25(2-3):263-71. PubMed ID: 15911222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2.
    Yoo HH; Lee M; Lee MW; Lim SY; Shin J; Kim DH
    Planta Med; 2007 May; 73(5):444-50. PubMed ID: 17566147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of Thai plant extracts on P-glycoprotein mediated efflux.
    Junyaprasert VB; Soonthornchareonnon N; Thongpraditchote S; Murakami T; Takano M
    Phytother Res; 2006 Jan; 20(1):79-81. PubMed ID: 16397849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers.
    He Y; Zeng S
    J Pharm Pharmacol; 2005 Oct; 57(10):1297-303. PubMed ID: 16259758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
    Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
    J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor.
    Iqbal J; Hombach J; Matuszczak B; Bernkop-Schnürch A
    J Control Release; 2010 Oct; 147(1):62-9. PubMed ID: 20603165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein mediated efflux in Caco-2 cell monolayers: the influence of herbals on digoxin transport.
    Oga EF; Sekine S; Shitara Y; Horie T
    J Ethnopharmacol; 2012 Dec; 144(3):612-7. PubMed ID: 23064285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein.
    Griffin J; Fletcher N; Clemence R; Blanchflower S; Brayden DJ
    J Vet Pharmacol Ther; 2005 Jun; 28(3):257-65. PubMed ID: 15953199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of P-glycoprotein-mediated efflux in the oral absorption of P-gp substrate drugs from simultaneous analysis of drug dissolution and permeation.
    Kataoka M; Yokoyama T; Masaoka Y; Sakuma S; Yamashita S
    Eur J Pharm Sci; 2011 Nov; 44(4):544-51. PubMed ID: 21963456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer.
    Sugihara N; Toyama K; Michihara A; Akasaki K; Tsuji H; Furuno K
    Toxicology; 2006 Jun; 223(1-2):156-65. PubMed ID: 16647797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products.
    Yoshida N; Koizumi M; Adachi I; Kawakami J
    Food Chem Toxicol; 2006 Dec; 44(12):2033-9. PubMed ID: 16904803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hr-IL2 treatment on intestinal P-glycoprotein expression and activity in Caco-2 cells.
    Belliard AM; Tardivel S; Farinotti R; Lacour B; Leroy C
    J Pharm Pharmacol; 2002 Aug; 54(8):1103-9. PubMed ID: 12195825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME; Podila L; Ely D; Almeida I
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of P-glycoprotein on clopidogrel absorption.
    Taubert D; von Beckerath N; Grimberg G; Lazar A; Jung N; Goeser T; Kastrati A; Schömig A; Schömig E
    Clin Pharmacol Ther; 2006 Nov; 80(5):486-501. PubMed ID: 17112805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.